Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with α-amanitin

Human and Experimental Toxicology

Volumn 30, Issue 1, 2011, Pages 38-43

  Magdalan, Jan ^a   Piotrowska, Aleksandra ^a   Gomułkiewicz, Agnieszka ^a   Sozański, Tomasz ^a   Szela̧g, Adam ^a   Dziegiȩl, Piotr ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

alpha amanitin; benzylpenicillin; catalase; N acetyl L cysteine; silibinin; superoxide dismutase

Indexed keywords

ACETYLCYSTEINE; ALPHA AMANITIN; CATALASE; HYDROGEN PEROXIDE; OXYGEN RADICAL; PENICILLIN G; SILIBININ; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; DRUG INTOXICATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIVER CELL CULTURE; PRIORITY JOURNAL;

ACETYLCYSTEINE; ALPHA-AMANITIN; AMANITA; ANTIDOTES; ANTIOXIDANTS; CATALASE; CELLS, CULTURED; HEPATOCYTES; HUMANS; LIPID PEROXIDATION; MUSHROOM POISONING; NUCLEIC ACID SYNTHESIS INHIBITORS; OXIDANTS; PENICILLIN G; SILYMARIN; SUPEROXIDE DISMUTASE;

AMANITA PHALLOIDES;

EID: 78650222313     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110368418     Document Type: Article

References (34)

1. Schneider SM Mushrooms. In: Ford MD, Delaney KA, Ling LJ, Erickson T (eds.) Clinical toxicology. Philadelphia, PA: W.B. Saunders Company, 2001, pp. 899-909.
2. Ellenhorn M. Ellenhorn's medical toxicology. Diagnosis and treatment of human poisoning. Baltimore: Williams & Wilkins, 1997.
3. Enjalbert A., Rapior S., Nouguier-Soulé J., Guillon S., Amouroux N., Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol 2002 ; 40: 715-757.
4. Escudié L., Francoz C., Vinel JP, et al. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 2007 ; 46: 466-473.
5. Jan MA, Siddiqui TS, Ahmed N., Ul Haq I., Khan Z. Mushroom poisoning in children: clinical presentation and outcome. J Ayub Med Coll Abbottabad 2008 ; 20: 99-101.
6. Vesconi S., Langer M., Iapichino G., Costantino D., Busi C., Fiume L. Therapy of cytotoxic mushroom intoxication. Crit Care Med 1985 ; 13: 402-406.
7. Wieland T. The toxic peptides from Amanita mushrooms. Int J Pept Protein Res 1983 ; 22: 257-276.
8. Letschert K., Faulstich H., Keller D., Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci 2006 ; 91: 140-149.
9. Nguyen VT, Giannoni F., Dubois MF, et al. In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin. Nucleic Acids Res 1996 ; 24: 2924-2929.
10. Zheleva A., Tolekova A., Zhelev M., et al. In vivo antioxidant and prooxidant properties of Amanita phalloides mushroom toxins. Trakia J Sci 2005 ; 3: 34-38.
11. Zheleva A., Gadjeva V., Zhelev M. Free radical formation might contribute to the severe amatoxin hepatotoxicity. Trakia J Sci 2003 ; 1: 42-45.
12. Zheleva A., Tolekova A., Zhelev M., Uzunova V., Platikanova M., Gadzheva V. Free radical reactions might contribute to severe alpha amanitin hepatotoxicity - a hypothesis. Med Hypotheses 2007 ; 69: 361-367.
13. Magdalan J., Ostrowska A., Piotrowska A., et al. Benzylpenicillin, acetylcysteine and silibinin as antidotes in human hepatocytes intoxicated with α-amanitin. Exp Toxicol Pathol 2009, in press, DOI 10.1016/ j.etp.2009.05.03.
14. Magdalan J., Ostrowska A., Piotrowska A., Gomulkiewicz A., Szelag A., Dziegiel P. Comparative antidotal efficacy of benzylpenicyllin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin. Arch Toxicol 2009 ; 83: 1091-1096.
15. Heilmeyer W., Plempel M., Otten H. Antibiotika-Fibel. Antibiotika und Chemotherapie. 3 Auflage. Stuttgart: Georg Thieme Verlag, 1969.
16. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989 ; 37: 501-506.
17. Kim YC, Kim EJ, Lee ED, et al. Comparative bioavailability of silibinin in healthy male volunteers. Int J Clin Pharmacol 2003 ; 41: 593-596.
18. Lorenz D., Lucker PW, Mennicke WH, Wetzelsberger N. Pharmacokinetic studies with silymarin in human serum and bile. Methods Find Exp Clin Pharmacol 1984 ; 6: 655-661.
19. Little MC, Preston JF Sensitivity of carrot cell cultures and RNA polymerase II to amatoxins. Evidence for the inactivation of 6'-hydroxyl-amatoxins. Plant Physiol 1985 ; 77: 443-449.
20. Zhelev AM, Michelot D., Zhelev ZhD. Sensitivity of alpha amanitin to oxidation by a lactoperoxidase-hydrogen peroxide system. Toxicon 2000 ; 38: 1055-1063.
21. Marklund S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol Scand Suppl 1980 ; 492: 19-23.
22. Deisseroth A., Dounce AL Catalase: physical and chemical properties, mechanism of catalysis and physiological role. Physiol Rev 1970 ; 50: 319-375.
23. Andera L., Wasylyk B. Transcription abnormalities potentiate apoptosis of normal human fibroblasts. Mol Med 1997 ; 12: 852-863.
24. Arima Y., Nitta M., Kuninaka S., et al. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem 2005 ; 280: 19166-19176.
25. Gartel AL Transcriptional inhibitors, p53 and apoptosis. Biochim Biophys Acta 2008 ; 1786: 83-86.
26. Ishihara Y., Shiba D., Shimamoto N. Primary hepatocyte apoptosis is unlikely to relate to caspase-3 activity under sustained endogenous oxidative stress. Free Radic Res 2005 ; 39: 163-173.
27. Leist M., Gantner F., Naumann H., et al. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 1997 ; 112: 923-934.
28. El-Bahay C., Gerber E., Horbach M., Tran-Thi QH, Röhrdanz E., Kahl R. Influence of tumor necrosis factor-alpha and silybin on the cytotoxic action of alpha-amanitin in rat hepatocyte culture. Toxicol Appl Pharmacol 1999 ; 158: 253-260.
29. Magdalan J., Pieniewska M., Gliniak H. The inhibition of α-amanitin uptake in perfused rat liver. Adv Clin Exp Med 2007 ; 16: 355-362.
30. Moldeus P., Cotgreave IA, Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration 1986 ; 50: 31-42.
31. Kawaji A., Sone T., Natsuki R., Isobe M., Takabatake E., Yamaura Y. In vitro toxicity test of poisonous mushroom extracts with isolated rat hepatocytes. J Toxicol Sci 1990 ; 12: 141-142.
32. De LaPuerta R., Martinez E., Bravo L., Ahumada C. Effects of silymarin on different acute inflammation models and on leukocyte migration. J Pharm Pharmacol 1996 ; 48: 968-970.
33. Saller R., Brignoli R., Melzer J., Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementärmed 2008 ; 15: 9-20.
34. Wellington K., Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001 ; 15: 465-489.